These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25119192)

  • 21. Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.
    Jacob SL; Field HP; Calder N; Picton HM; Balen AH; Barth JH
    Clin Endocrinol (Oxf); 2017 Mar; 86(3):395-400. PubMed ID: 27805276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.
    Dewailly D; Gronier H; Poncelet E; Robin G; Leroy M; Pigny P; Duhamel A; Catteau-Jonard S
    Hum Reprod; 2011 Nov; 26(11):3123-9. PubMed ID: 21926054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients.
    Aleyasin A; Aghahoseini M; Mokhtar S; Fallahi P
    Acta Med Iran; 2011; 49(11):715-20. PubMed ID: 22131240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY; Lu LK; Li M; Zhang QL; Ying CM
    PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome.
    Timur HT; Cimrin D; Gursoy Doruk O; Dogan OE
    Curr Med Res Opin; 2023 Jun; 39(6):855-863. PubMed ID: 37074782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C; Fanelli F; Pariali M; Zanotti L; Gambineri A; Pasquali R
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1575-82. PubMed ID: 23928669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Anti-müllerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome.
    Ozay AC; Emekcı Ozay O; Gulekli B
    Ginekol Pol; 2020; 91(11):661-667. PubMed ID: 33301159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
    Matsuzaki T; Munkhzaya M; Iwasa T; Tungalagsuvd A; Yano K; Mayila Y; Yanagihara R; Tokui T; Kato T; Kuwahara A; Matsui S; Irahara M
    Endocr J; 2017 May; 64(5):531-541. PubMed ID: 28381699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimüllerian hormone to determine polycystic ovarian morphology.
    Dietz de Loos A; Hund M; Buck K; Meun C; Sillman J; Laven JSE
    Fertil Steril; 2021 Oct; 116(4):1149-1157. PubMed ID: 34579824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries.
    Rosenfield RL; Wroblewski K; Padmanabhan V; Littlejohn E; Mortensen M; Ehrmann DA
    Fertil Steril; 2012 Jul; 98(1):242-9. PubMed ID: 22541936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G; Mumusoglu S; Coskun ZY; Yarali H; Yildiz BO
    Reprod Biomed Online; 2019 Sep; 39(3):522-529. PubMed ID: 31182353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.
    Romualdi D; Di Florio C; Tagliaferri V; De Cicco S; Gagliano D; Immediata V; Lanzone A; Guido M
    Reprod Sci; 2016 May; 23(5):655-61. PubMed ID: 26718304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
    Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome.
    Qi X; Pang Y; Qiao J
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P; Jonard S; Robert Y; Dewailly D
    J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.